Although the use of cost-effectiveness analysis has been increasing in Brazil, there is no evidence of an appropriate willingness-to-pay value to interpret results. The objective of this study is to develop an alternative model to support reimbursement decisions of private payers in Brazil.
A committee was created by ANS in 2014 to evaluate new health technologies in the private system, and their current approach to decision-making involves a set of meetings with experts to discuss requests from the group. In this context, Multi-Criteria Decision Analysis (MCDA) may provide a structured and reproducible framework to support decisions involving multiple stakeholders.
The objective of this study is to develop an alternative model to support reimbursement decisions of private payers in Brazil.
METHODS:
A value measurement Multi Criteria Decision Analysis (MCDA) model was developed in order to reflect different dimensions that influence healthcare decisions. A literature review was performed in order to identify the most common dimensions, criteria and scores scales to be included in the model, which was further complemented by expert opinion.
Analytical hierarchy process was used to weight the importance of each dimension and criteria by pairwise comparisons. A group representing different stakeholders (academia, payer, industry and physician) was formed in order to consider different perspectives when validating the final model. Figure 1 presents the framework of the MCDA model development. 
RESULTS:
A simple linear additive model with four dimensions (clinical impact, strength of the evidence, economic impact and feasibility of adoption) was developed based on the literature. After validation by expert opinion, these 4 dimensions were divided into a total of 10 criteria: "treatment costs", "indication prevalence", "level of evidence", "relevance of outcome", "impact on health", "severity of disease", "feasibility of adoption", "legal implications", "ethical implications" and "technology positioning" An electronic survey by e-mail to weight criteria by AHP was answered by 10 people (10% from service providers, 10% from payers, 20% from the industry and 60% from others). Legal implications and ethical implications were not part of the survey and were given disproportional values in the final model, as these were considered mandatory requirements. The final score was then classified into 5 options based on the likelihood of recommendation, in a tool nominated the "weight of recommendation": 
LIMITATIONS:
A linear additive model approach was used. It may not reflect actual preferences since some criteria might be interdependent (e.g., level of evidence and impact on health);
Only a small sample of people answered the survey, which may not be representative of the total Health System;
CONCLUSION
The proposed MCDA model may provide additional support to prioritize and guide reimbursement decisions for individual payers in the private Health System in Brazil. Intervalo da faixa 17,01786
Total de faixas sugeridas 5
